|
EP3541396A4
(en)
|
2016-11-18 |
2020-07-22 |
Arcus Biosciences, Inc. |
CD73-MEDIATED IMMUNOSUPPRESSION INHIBITORS
|
|
CN110382544B
(zh)
|
2017-03-16 |
2023-12-22 |
先天制药公司 |
用于治疗癌症的组合物和方法
|
|
WO2018208980A1
(en)
|
2017-05-10 |
2018-11-15 |
Oric Pharmaceuticals, Inc. |
Cd73 inhibitors
|
|
WO2019068907A1
(en)
|
2017-10-06 |
2019-04-11 |
Innate Pharma |
RESTORATION OF T CELL ACTIVITY BY AXIS CD39 / CD73
|
|
US11377469B2
(en)
|
2017-11-03 |
2022-07-05 |
Oric Pharmaceuticals, Inc. |
CD73 inhibitors
|
|
JP7417530B2
(ja)
|
2018-03-09 |
2024-01-18 |
アーカス バイオサイエンシズ インコーポレイティド |
優先投与される免疫増強薬
|
|
CN112423764A
(zh)
|
2018-04-30 |
2021-02-26 |
欧瑞克制药公司 |
Cd73抑制剂
|
|
EP3810109B1
(en)
|
2018-05-31 |
2024-08-07 |
Peloton Therapeutics, Inc. |
Compounds and compositions for inhibiting cd73
|
|
MX2020012107A
(es)
|
2018-06-18 |
2021-01-29 |
Innate Pharma |
Composiciones y procedimientos para el tratamiento del cancer.
|
|
US11332492B2
(en)
|
2018-08-28 |
2022-05-17 |
Jiangsu Hengrui Medicine Co., Ltd. |
CD73 inhibitors and therapeutic uses thereof
|
|
CN110885352B
(zh)
*
|
2018-09-11 |
2023-02-24 |
润佳（苏州）医药科技有限公司 |
Cd73抑制剂及其药学应用
|
|
US11530234B2
(en)
|
2018-09-11 |
2022-12-20 |
Risen (Suzhou) Pharma Tech Co., Ltd. |
CD73 inhibitors and pharmaceutical uses thereof
|
|
US10881681B2
(en)
|
2018-09-11 |
2021-01-05 |
Risen (Suzhou) Pharma Tech Co., Ltd. |
CD73 inhibitors and pharmaceutical uses thereof
|
|
US20200345725A1
(en)
|
2019-01-11 |
2020-11-05 |
Omeros Corporation |
Methods and Compositions for Treating Cancer
|
|
CN112955444B
(zh)
*
|
2019-01-22 |
2023-12-12 |
江苏恒瑞医药股份有限公司 |
一种新型的小分子cd73抑制剂、其制备方法及其在医药上的应用
|
|
WO2020185859A1
(en)
|
2019-03-12 |
2020-09-17 |
Arcus Biosciences, Inc. |
Treatment of oncogene-driven cancers
|
|
US12310965B2
(en)
|
2019-03-29 |
2025-05-27 |
Arcus Biosciences, Inc. |
Treatment of cancer utilizing an identified adenosine fingerprint
|
|
US12544391B2
(en)
|
2019-07-16 |
2026-02-10 |
Oric Pharmaceuticals, Inc. |
CD73 inhibitors
|
|
HUE072504T2
(hu)
|
2019-10-30 |
2025-11-28 |
Oric Pharmaceuticals Inc |
CD73-inhibitorok
|
|
CN115298165B
(zh)
|
2020-03-19 |
2024-09-17 |
艾库斯生物科学有限公司 |
作为HIF-2α抑制剂的四氢化萘和四氢喹啉化合物
|
|
BR112022024221A2
(pt)
|
2020-06-02 |
2022-12-20 |
Arcus Biosciences Inc |
Anticorpos para tigit
|
|
EP4251633A4
(en)
*
|
2020-11-25 |
2024-09-25 |
Risen (Suzhou) Pharma Tech Co., Ltd. |
CD73 INHIBITORS AND PHARMACEUTICAL USES THEREOF
|
|
JP2024521712A
(ja)
|
2021-05-21 |
2024-06-04 |
アーカス バイオサイエンシーズ，インコーポレーテッド |
Ａｘｌ阻害化合物
|
|
CN117295741A
(zh)
|
2021-05-21 |
2023-12-26 |
艾库斯生物科学有限公司 |
Axl化合物
|
|
WO2023077046A1
(en)
|
2021-10-29 |
2023-05-04 |
Arcus Biosciences, Inc. |
Inhibitors of hif-2alpha and methods of use thereof
|
|
CN119173276A
(zh)
|
2022-04-13 |
2024-12-20 |
吉利德科学公司 |
用于治疗表达Trop-2的癌症的组合疗法
|
|
CA3256561A1
(en)
|
2022-05-02 |
2023-11-09 |
Arcus Biosciences, Inc. |
Anti-tigit antibodies and their uses
|
|
JP2025520300A
(ja)
*
|
2022-06-17 |
2025-07-03 |
上海森輝医薬有限公司 |
シクロペンチルアデノシン誘導体及びその医薬的使用
|
|
EP4554680A1
(en)
|
2022-07-15 |
2025-05-21 |
Arcus Biosciences, Inc. |
Inhibitors of hpk1 and methods of use thereof
|
|
US20260028336A1
(en)
|
2022-07-20 |
2026-01-29 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
CN119768155A
(zh)
|
2022-09-14 |
2025-04-04 |
艾库斯生物科学有限公司 |
依曲地南的分散体
|
|
WO2024081385A1
(en)
|
2022-10-14 |
2024-04-18 |
Arcus Biosciences, Inc. |
Hpk1 inhibitors and methods of use thereof
|
|
EP4705292A1
(en)
|
2023-05-05 |
2026-03-11 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
CN116298323B
(zh)
*
|
2023-05-16 |
2023-08-22 |
南京联笃生物科技有限公司 |
一种用于诊断狼疮性肾炎的生物标志物及应用
|
|
US20250011318A1
(en)
|
2023-05-25 |
2025-01-09 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
WO2025054339A1
(en)
|
2023-09-08 |
2025-03-13 |
Arcus Biosciences, Inc. |
Triazolopyridine compounds as inhibitors of kit
|
|
WO2025072330A1
(en)
|
2023-09-26 |
2025-04-03 |
Arcus Biosciences, Inc. |
Kit inhibitor compounds and methods of use thereof
|
|
WO2025076299A1
(en)
|
2023-10-06 |
2025-04-10 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
TW202523302A
(zh)
|
2023-11-02 |
2025-06-16 |
美商阿克思生物科學有限公司 |
噻唑化合物及其使用方法
|
|
WO2025119278A1
(zh)
*
|
2023-12-07 |
2025-06-12 |
无锡和誉生物医药科技有限公司 |
一种cd73抑制剂药物组合物，其制备方法和应用
|
|
WO2025137640A1
(en)
|
2023-12-22 |
2025-06-26 |
Gilead Sciences, Inc. |
Azaspiro wrn inhibitors
|
|
WO2025193759A1
(en)
|
2024-03-12 |
2025-09-18 |
Gilead Sciences, Inc. |
Solid forms of an azolopyrimidine compound
|
|
WO2025233264A1
(en)
|
2024-05-07 |
2025-11-13 |
Innate Pharma |
Use of cd73 blocking agents in combination with anti-cd20 x cd3 t cell engagers
|
|
WO2026006759A1
(en)
|
2024-06-28 |
2026-01-02 |
Arcus Biosciences, Inc. |
Pharmaceutical compositions, dosage forms, and methods of making and using same
|